News - USA, Vascepa


Current filters:


Popular Filters

Amarin and Kowa Pharma to co-promote Vascepa in USA


US biotech firm Amarin Corp and Kowa Pharmaceuticals America, owned by Japan’s Kowa, have reached an…

AmarinBiotechnologyCardio-vascularKowa PharmaceuticalsMarkets & MarketingNorth AmericaUSAVascepa

Amarin files suit against AstraZeneca over Epanova

Amarin files suit against AstraZeneca over Epanova


US biotech firm Amarin revealed in a Stock Exchange Commission submission that it has filed a complaint…

AmarinAstraZenecaBiotechnologyCardio-vascularEpanovaLegalNorth AmericaOmthera PharmaceuticalsPatentsUSAVascepa

Amarin calls on FDA to extend Vascepa exclusivity by five years


US biotech firm Amarin has filed with a federal court requesting it to order the US Food and Drug Administration…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLegalLovazaNorth AmericaUSAVascepa

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top